Individualized Neuro-Modulation Paired With Cerebellar Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorHugo W. Moser Research Institute at Kennedy Krieger, Inc.

About this trial

The purpose of this project is to evaluate feasibility and preliminary efficacy of pairing personalized transcranial direct current stimulation (tDCS) with individualized rehabilitation therapy in people with cerebellar damage.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18-75 years

Males and Females

Disorders that predominantly affect the cerebellum: damage from stroke, tumor or degeneration (genetic or non-genetic causes, congenital hypoplasia).

Disqualifiers

Diagnoses or impairments that interfere with task execution or data interpretation.

Heart pacemaker or other MRI-incompatible implanted metal device

Metallic foreign body in their eye or head

Experience with severe claustrophobia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Therapy

    Behavioral

    Each participant will choose a domain that they would like to focus on. Choices are: 1) walking and balance control, 2) hand dexterity and arm control, or 3) speech articulation, prosody, and intelligibility.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Active stimulation combined with therapy.Experimental treatment 1 intervention
Group B: Sham stimulation combined with therapy.Sham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Scale for the Assessment and Rating of Ataxia (SARA)

The SARA is a tool for assessing ataxia. SARA is an 8-item performance based scale, yielding a total score of 0 (no ataxia) to 40 (most severe ataxia). The scores are based on patient performance of: gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating hand movements, heel-shin slide.

Time frame
Assessed at pre-treatment, post-treatment, and at 3- and 6-month follow-ups.
2

Patient-Reported Outcome Measure of Ataxia

The PROM-Ataxia is a self reported questionnaire used by researchers to evaluate the daily impact and progression of cerebellar ataxia directly from the patient's perspective. The questionnaire encompasses 70 total items within 3 main domains: 1) Physical: Gait, manual dexterity, swallowing (dysphagia), and visual/ocular motor control. 2) Activities of Daily Living (ADL): Managing household chores, employment, driving, and self-care. 3)Mental: Mood, anxiety, motivation, and cognitive tasks (e.g., multitasking and comprehension).

Time frame
Assessed at pre-treatment, post-treatment, and at 3- and 6-month follow-ups.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.